Furthermore, overexpression of NUCB1 in SW1990 and CFPAC1 notably increased the anti-tumor effects of gemcitabine (GEM) compared to control vector, as indicated by increased apoptosis of NUCB1-overexpressing cells compared to control cells (Figures 2G,H). This evidence concerns the gene NUCB1 and neoplasm.